| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |